Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alpha Healthcare Acquisition Corp. III stock logo
ALPA
Alpha Healthcare Acquisition Corp. III
$3.14
$8.73
$11.83
$8.92M0.03128,666 shs85,427 shs
GBS Inc. stock logo
GBS
GBS
$1.78
-3.8%
$1.42
$0.36
$2.89
$26.50M1.32955,325 shs375,633 shs
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
$3.01
+0.7%
$2.89
$9.41
$13.80
$33.75M0.09205,918 shs250,716 shs
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$0.22
-22.2%
$0.29
$0.03
$1.00
$3.73M1.2674,785 shs2,988 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alpha Healthcare Acquisition Corp. III stock logo
ALPA
Alpha Healthcare Acquisition Corp. III
0.00%0.00%0.00%0.00%-72.17%
GBS Inc. stock logo
GBS
GBS
-2.63%-2.63%+44.53%-14.35%-2.12%
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
0.00%-5.38%+2.40%-33.70%-59.81%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.00%0.00%-22.61%-39.86%+580.53%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alpha Healthcare Acquisition Corp. III stock logo
ALPA
Alpha Healthcare Acquisition Corp. III
N/AN/AN/AN/AN/AN/AN/AN/A
GBS Inc. stock logo
GBS
GBS
N/AN/AN/AN/AN/AN/AN/AN/A
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
N/AN/AN/AN/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alpha Healthcare Acquisition Corp. III stock logo
ALPA
Alpha Healthcare Acquisition Corp. III
0.00
N/AN/AN/A
GBS Inc. stock logo
GBS
GBS
0.00
N/AN/AN/A
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
0.00
N/AN/AN/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alpha Healthcare Acquisition Corp. III stock logo
ALPA
Alpha Healthcare Acquisition Corp. III
N/AN/AN/A923.23($0.31) per shareN/A
GBS Inc. stock logo
GBS
GBS
$440K60.24N/AN/A$0.44 per share4.05
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
N/AN/AN/AN/A($0.62) per shareN/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$17.63M1.40$10.80 per share0.02$1.05 per share0.21
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alpha Healthcare Acquisition Corp. III stock logo
ALPA
Alpha Healthcare Acquisition Corp. III
$200KN/A0.00N/AN/AN/A-28.55%0.84%N/A
GBS Inc. stock logo
GBS
GBS
-$8.31M-$0.56N/AN/AN/AN/A-85.64%-54.42%N/A
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
-$380KN/A0.00N/AN/AN/A-2.38%N/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$6.95M$0.05N/AN/AN/A-82.31%-51.47%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alpha Healthcare Acquisition Corp. III stock logo
ALPA
Alpha Healthcare Acquisition Corp. III
N/AN/AN/AN/AN/A
GBS Inc. stock logo
GBS
GBS
N/AN/AN/AN/AN/A
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
N/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alpha Healthcare Acquisition Corp. III stock logo
ALPA
Alpha Healthcare Acquisition Corp. III
N/A
0.05
0.05
GBS Inc. stock logo
GBS
GBS
N/A
2.33
2.33
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
N/A
0.17
0.61
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/A
3.73
3.73
CompanyEmployeesShares OutstandingFree FloatOptionable
Alpha Healthcare Acquisition Corp. III stock logo
ALPA
Alpha Healthcare Acquisition Corp. III
2,02119.31 millionN/ANot Optionable
GBS Inc. stock logo
GBS
GBS
714.89 million14.85 millionNot Optionable
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
411.21 million8.76 millionNot Optionable
Titan Medical Inc. stock logo
TMDIF
Titan Medical
50114.04 million4.56 millionNot Optionable

Recent News About These Companies

Titan Announces Resignations of Directors
Proxy Deadline Thursday September 26, 2024
Titan Announces Q&A Session with Shareholders
Titan Medical | Morning Blend
Titan Medical Inc. (QTNA.SG)

Media Sentiment Over Time

Alpha Healthcare Acquisition Corp. III stock logo

Alpha Healthcare Acquisition Corp. III NASDAQ:ALPA

Alpha Healthcare Acquisition Corp. III does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.

GBS stock logo

GBS NYSE:GBS

$1.78 -0.07 (-3.78%)
As of 06/20/2025

GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Health Sciences Acquisitions Co. 2 stock logo

Health Sciences Acquisitions Co. 2 NASDAQ:HSAQ

$3.01 +0.02 (+0.67%)
As of 06/20/2025

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.

Titan Medical stock logo

Titan Medical NASDAQ:TMDIF

$0.22 -0.06 (-22.20%)
As of 06/20/2025

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.